(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CBD PHARM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CBD PHARM

ST13

US500000088624830

Class

34

Filing

88624830

Registration

7032727

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

04/18/2023

Trademark type

Word

Nice classes

34

Filing date

09/20/2019

Registration date

04/18/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/18/2023

Last transaction

04/18/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

First use anywhere

01/01/2019

First use in commerce

03/01/2019

Drawing code

4

Owner type

16

Owner location

Rolling Meadows, IL

Examiner

WOLFE, YOUNG

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Happiness Holdings, LLC

Representatives

Christopher J. Day Day Law Firm

Technical classification

Nice Classes

Class 34

Vienna Codes

No Vienna codes available.

Goods and services

Class 34

Oral vaporizers for smoking purposes; all of the foregoing sold filled with liquids containing cannabidiol (CBD)other than essential oilssolely derived from hemp with a delta-9 tetrahydrocannabinol (THC) of not more than 0.3 percent on a dry weight basis

Publications

History of USPTO decisions and trademark events.

32 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/18/2023

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

04/18/2023

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/16/2023

ALIE

ASSIGNED TO LIE

03/15/2023

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/08/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

03/08/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/08/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

03/08/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/08/2023

DOCK

ASSIGNED TO EXAMINER

03/08/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

03/05/2023

DOCK

ASSIGNED TO EXAMINER

03/01/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

01/27/2023

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

05/20/2022

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

10/13/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

03/25/2021

ALIE

ASSIGNED TO LIE

03/24/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/15/2020

GNSL

LETTER OF SUSPENSION E-MAILED

06/15/2020

CNSL

SUSPENSION LETTER WRITTEN

06/15/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/12/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/11/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/11/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/12/2020

GNRT

NON-FINAL ACTION E-MAILED

05/12/2020

CNRT

NON-FINAL ACTION WRITTEN

05/12/2020

DOCK

ASSIGNED TO EXAMINER

05/11/2020

DOCK

ASSIGNED TO EXAMINER

05/05/2020

DOCK

ASSIGNED TO EXAMINER

04/27/2020

DOCK

ASSIGNED TO EXAMINER

10/05/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/26/2019

NWAP

NEW APPLICATION ENTERED

09/24/2019

Continuous trademark protection

Get notified about every new filing that threatens CBD PHARM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.